Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
Trade global traditional assets with USDT in one place
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and enjoy airdrop rewards!
Futures Points
Earn futures points and claim airdrop rewards
Investment
Simple Earn
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Soft Staking
Earn rewards with flexible staking
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-stop lending hub
VIP Wealth Hub
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Quant Fund
Top asset management team helps you profit without hassle
Staking
Stake cryptos to earn in PoS products
Smart Leverage
New
No forced liquidation before maturity, worry-free leveraged gains
GUSD Minting
Use USDT/USDC to mint GUSD for treasury-level yields
Microchip Biotech: Plans to provide 350 million yuan to its wholly-owned subsidiary to support the advancement of the new drug manufacturing base project
Recently, Microchip Biotech announced that the company has decided to use part of the raised funds to make capital contributions, increase capital, and provide loans to its wholly-owned subsidiary Pengzhou Microchip Pharmaceutical Co., Ltd. to implement the fundraising project.
The specific amounts are 30.8 million yuan for capital contributions, 40 million yuan for capital increase, and 279 million yuan for loans, totaling 350 million yuan. The funds will be exclusively used for the “Pengzhou Microchip Original Innovation Drug Manufacturing Base (Phase I) Project.”
After this capital increase, Pengzhou Microchip’s registered capital will increase to 100 million yuan, remaining a wholly-owned subsidiary of the company. The total amount of funds raised, as mentioned in the announcement, is 950 million yuan, with a net amount of 933 million yuan after deducting related expenses.
The company stated that this fund usage aligns with its long-term strategic development plan, aims to optimize resource allocation, improve overall resource utilization efficiency, and does not constitute related-party transactions or major asset restructuring.
(Microchip Biotech Announcement)
(Edited by: Yang Yan, Lin Chen)
Keywords: Healthcare